Study finds no benefit to intensive treatment for early type 2 diabetes

08/24/2011 | Medscape (free registration)

Data on more than 1,500 Danish participants with type 2 diabetes found that those in an intensive treatment group had a 7.3% prevalence of ankle-brachial index of 0.9 or less and 30.1% of participants had abnormal neuropathy results six years after screening, compared with 9.1% and 34.8% respectively in the routine care group. The researchers, writing in Diabetes Care, concluded there was no statistically significant effect of intensive management upon early detection of type 2 diabetes.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Counsel II, Legal (Anti-corruption)
Gilead Sciences
Foster City, CA
Director, Health Plan Operations
Group Health Cooperative
Seattle, WA
Assistant General Counsel - Pharmaceutical R&D
GlaxoSmithKline
Multiple Locations, SL_Multiple Locations
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA